Change over period: —
NSE · PAR
Par Drugs & Chemicals Ltd
-32.6% from the 52-week high · +44.3% above the low
Par Drugs & Chemicals Ltd. engages in the development and manufacture of Active Pharma Ingredients (API) for the domestic market as well as for exports to international markets. The company is headquartered in Bhavnagar, Gujarat. The company went IPO on 2019-05-16. The firm also produces a range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide and sucralfate USP. The firm owns and operates its manufacturing facilities at Bhavnagar in Gujarat. The company has over four manufacturing blocks at Bhavnagar, which are for different products having a capacity of approximately 9,700 metric tons per annum.
The short version. Promoter holding was 73.41% in Sep 2026, up 0.04 points over 8 quarters.
1 · The price
How has the stock traded?
Par Drugs & Chemicals Ltd trades 32.6% below its 52-week high and 44.3% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Up 0.04 pts over 8 quarters.
Up 0.09 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.37 | 73.37 | 73.37 | 73.37 | 73.41 | 73.41 | 73.41 | 73.41 | +0.04 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0.09 | +0.09 |
| Public | 26.63 | 26.63 | 26.63 | 26.63 | 26.59 | 26.59 | 26.51 | 26.51 | -0.12 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for Par Drugs & Chemicals Ltd are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about Par Drugs & Chemicals Ltd
What is the Par Drugs & Chemicals Ltd share price?
Par Drugs & Chemicals Ltd (PAR) last closed at ₹114.95, up 1.4% on the day. Its 52-week range is ₹78.58 to ₹168.25.
What is the market cap of Par Drugs & Chemicals Ltd?
Par Drugs & Chemicals Ltd has a market capitalisation of about ₹139 crore. Its price-to-earnings ratio is 10.7.
How are Par Drugs & Chemicals Ltd's latest results?
Promoter holding was 73.41% in Sep 2026, up 0.04 points over 8 quarters.
Who owns Par Drugs & Chemicals Ltd?
As of Sep 2026, shareholding was: Promoter 73.41%, DII 0.09%, Public 26.51%.
How many mutual funds hold Par Drugs & Chemicals Ltd?
0 mutual fund schemes held Par Drugs & Chemicals Ltd in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 22 Nov 2021 · Interim Dividend - Rs. 1.25
- 27 Apr 2021 · Bonus issue 1:1
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.